Royalty Pharma plc
Status: Publicly traded
Direct answer
Royalty Pharma plc is publicly traded on NASDAQ under the ticker RPRX.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was...
Can you invest in Royalty Pharma plc?
Yes. Royalty Pharma plc is publicly traded on NASDAQ under the ticker RPRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Royalty Pharma plc
Detailed equity research is provided by MarketSnap.